<DOC>
	<DOCNO>NCT00944463</DOCNO>
	<brief_summary>The purpose study determine whether simvastatin effective treatment advance pancreatic cancer patient .</brief_summary>
	<brief_title>Trial Simvastatin Gemcitabine Pancreatic Cancer Patients</brief_title>
	<detailed_description>Randomized double-blinded , placebo-controlled phase II trial simvastatin gemcitabine advance pancreatic cancer patient .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Age &gt; 18 year 2 . Histologically cytologically confirm , metastatic unresectable pancreatic adenocarcinoma ( repeat biopsy ( &gt; 3 ) fail biopsy feasible , inclusion patient determine central PI ) 3 . ECOG performance status 0~2 4. radiotherapy within 1 month study entry 5. measurable evaluable lesion accord RECIST criterion 6. prior history chemotherapy pancreatic cancer ( gemcitabinebased adjuvant chemotherapy ≥ 12 month study entry allow ) 7. adequate marrow , hepatic , renal cardiac function ( absolute neutrophil count ≥ 1.5 x 109/L ; platelet count ≥ 75 x 109/L , serum creatinine ≤ 1.5 x ULN ) , serum aspartate aminotransferase/alanine aminotransferase ≤ 5 x ULN ≤ 10 x ULN liver abnormality due underlying malignancy ; total bilirubin ≤ 2.0 x ULN 8. write informed consent must provide 1. severe comorbid illness and/or active infection 2. pregnant lactate woman 3. active CNS metastasis controllable radiotherapy corticosteroid A.patients symptom suggestive CNS metastasis must undergo radiologic evaluation rule metastases B.patients know , asymptomatic CNS lesion permit 4. known history hypersensitivity study drug 5. patient currently statin therapy take statin lipid lower agent within 1 year study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>advanced pancreatic cancer</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>simvastatin</keyword>
	<keyword>placebo</keyword>
</DOC>